|
Press Releases |
|
|
|
Thursday, May 2, 2024 |
|
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024 |
The 16th Annual Global CSR & ESG Summit and Awards 2024 came to a triumphal close, marking another milestone in the realm of achievable corporate social responsibility (CSR) and environmental, social, and governance (ESG) initiatives. more info >> |
|
Thursday, June 29, 2023 |
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
Tuesday, December 6, 2022 |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
Monday, April 19, 2021 |
|
Sanofi Renews Partnership with Cielo to Strengthen its Talent Acquisition Strategy in Asia |
Cielo, the world's leading Recruitment Process Outsourcing (RPO) provider, has renewed its partnership with Sanofi, a global biopharmaceutical company, to help them hire the best talent in Asia. more info >> |
|
Friday, April 26, 2019 |
|
Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER |
Sanofi delivered strong Q1 2019 business EPS growth of 9.4% at CER. more info >> |
|
Thursday, February 7, 2019 |
|
Sanofi delivers 2018 business EPS growth of 5.1% at CER |
Sanofi announced the 2018 fourth-quarter and full-year results. more info >> |
|
Wednesday, February 7, 2018 |
|
Sanofi Delivers 2017 Business EPS in line with Guidance |
Sanofi Delivers 2017 Business EPS in line with Guidance more info >> |
|
Monday, January 22, 2018 |
|
Sanofi to Acquire Bioverativ for $11.6 Billion |
Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ for $105 per share in cash, representing an equity value of approximately $11.6 billion (on a fully diluted basis). The transaction was unanimously approved by both the Sanofi and Bioverativ Boards of Directors. more info >> |
|
Friday, October 6, 2017 |
|
Sanofi: Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent(R) (alirocumab) |
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent injunction in the dispute concerning Amgen's asserted patent claims for antibodies targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). This ruling means that Sanofi and Regeneron will continue marketing, selling and manufacturing Praluent(R) (alirocumab) injection in the U.S. more info >> |
|
Thursday, February 13, 2014 |
|
A*STAR, NUS and NUH Join Forces to Understand Immune Erosion in Elderly |
A*STAR's Singapore Immunology Network (SIgN) signed a three-year partnership with the National University of Singapore (NUS), National University Hospital (NUH) and Sanofi Pasteur to embark on a Phase IV clinical trial to understand age-related loss of immunity, known as immunosenescence, in elderly. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Shaping the Future of Technology with AI Everywhere Take Center Stage at the 13th Big CIO Show
May 10, 2024 20:55 HKT/SGT
|
|
|
DOCOMO to Launch "NTT DOCOMO GLOBAL" for Global Expansion
May 10, 2024 18:13 JST
|
|
|
Japan Energy Summit and Exhibition Hosts and Sponsors Demonstrate the Importance of Accelerating Decarbonisation
May 10, 2024 16:04 HKT/SGT
|
|
|
Pertamina International Shipping (PIS) Welcomes 2 VLGC Tankers to Its Fleet, Takes Top-Tier Position in ASEAN LPG Transport
May 10, 2024 16:00 HKT/SGT
|
|
|
Q2 Metals Announces Assay Results from Its 2024 Winter Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada
May 10, 2024 15:09 HKT/SGT
|
|
|
三菱重工など、電力系統の混雑緩和を実現するシステムのフィールド実証を開始
May 10, 2024 11:50: JST
|
|
|
Release of "Fugaku-LLM" - a large language model trained on the supercomputer "Fugaku"
May 10, 2024 12:20 JST
|
|
|
InfoComm Asia 2024 "Asia's International Pro AV Exhibition" Returns to Thailand
May 10, 2024 10:30 HKT/SGT
|
|
|
BLUETTI Unlocks Special Mother's Day Offerings, Perfect Gift Ideas for Moms
May 10, 2024 10:00 HKT/SGT
|
|
|
AGILON HEALTH (NYSE: AGL) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Agilon Health Investors of a Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:33 HKT/SGT
|
|
|
SSR MINING (SSRM) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies SSR Mining Investors of a Class Action Lawsuit and May 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:26 HKT/SGT
|
|
|
CHEMOURS (NYSE: CC) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:20 HKT/SGT
|
|
|
DOXIMITY (NYSE: DOCS) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and June 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:13 HKT/SGT
|
|
|
特步宣布战略性出售K-Swiss及帕拉丁 并优化财务结构
May 9, 2024 20:28 HKT/SGT
|
|
|
特步宣佈戰略性出售K-Swiss及帕拉丁 並優化財務結構
May 9, 2024 20:25 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|